A retrospective study described a child [age and sex not stated], who developed nausea during treatment with atomoxetine. The child with attention-deficit/hyperactivity disorder (ADHD) started to receive oral atomoxetine solution [dose not stated]. The child stopped taking atomoxetine because of continuous nausea [duration of treatment to reaction onset and outcome not stated]. …
Anzeige
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten